Suven Life Sciences informs about appointment of CS cum CO

29 Jan 2026 Evaluate
Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015, as amended and other applicable provisions of law, Suven Life Sciences has informed that the Board of Directors of the company, at its meeting held today i.e. January 29, 2026, has considered and approved the following along with other business matters: Allotment of 44,77,612 Equity Shares of the Company on preferential basis upon conversion 44,77,612 fully paid warrants; Resignation of Shrenik Soni, Company Secretary & Compliance Officer (KMP) of the Company; and appointment of Sangeetha Laxmi Kandari (ICSI M. No. A40736) as Company Secretary & Compliance Officer of the Company (Key Managerial Personnel).

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

139.30 6.50 (4.89%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×